## [Contract manufacturing](/about/manufacturing/contract-manufacturing "Contract manufacturing") We support complex, multi‑modality manufacturing and solve challenges across scale‑up, compliance, and global supply. Our partnership‑led approach combines expert people with proven execution to deliver reliable outcomes and regulatory confidence. [Contact our team](/about/manufacturing/contract-manufacturing/contact "Contract manufacturing contact form") ## Proven Excellence, Built by People Put your manufacturing challenges in our hands. We treat every client’s process as if it were our own—because you, and your patients, depend on it. Our people are at the heart of what we do. From our people on the ground at our plants to our senior leadership, Novartis is committed to contract manufacturing long term. Our reputation is built on the results we deliver for our partners. ![Person in a white top sitting indoors in an office](/sites/novartis_com/files/styles/crop_freeform/public/2026-06/person-in-a-white-top-sitting-indoors-in-an-office.png.webp?itok=aTxzgaiN "Person in a white top sitting indoors in an office") ### People First ![Sky view Novartis pavillon](/sites/novartis_com/files/styles/crop_freeform/public/2026-06/sky-view-novartis-pavillon.png.webp?itok=HuGbadMt "Sky view Novartis pavillon") ### Commitment at Every Level ![Woman scientist in a lab](/sites/novartis_com/files/styles/crop_freeform/public/2026-06/woman-scientist-lab-v3.png.webp?itok=xHASAJ3M "Woman scientist in a lab") ### Flexible Global Network --- ![Trophy icon](/sites/novartis_com/files/styles/crop_freeform/public/2026-06/trophy-icon.png.webp?itok=lcXttZuG "Trophy icon") ### Results-driven execution *in all manufacturing environments provides predictable outcomes and regulatory confidence.* --- ## Technologies Offering ### Mammalian Drug Substance (DS) ![Y Chromosome icon](/sites/novartis_com/files/styles/crop_freeform/public/2026-06/y-chromosome-icon.png.webp?itok=rRYvGZSl "Y Chromosome icon") #### Clinical to commercial GMP manufacturing at scale Multiproduct mammalian cell culture manufacturing for monoclonal antibodies and other recombinant biologics, supporting programs from late clinical development through commercial supply. Our integrated manufacturing model enables partners to select the optimal production scale for each lifecycle phase, while ensuring smooth tech transfer, process robustness, and supply reliability. **Key capabilities** - Mammalian cell culture drug substance manufacturing - Scalable production volumes from 200 L up to 15,000 L - Options for Single Use, Stainless Steel and Hybrid set ups - Extensive experience in fed batch, N-1 perfusion and continuous manufacturing --- ### Microbial Drug Substance (DS) ![Molecule icon](/sites/novartis_com/files/styles/crop_freeform/public/2026-06/molecule-icon.png.webp?itok=LDcDi7aB "Molecule icon") #### Flexible GMP manufacturing within a single site Efficient scale selection for biologic drug substance production within a single, integrated GMP site, supporting both clinical and commercial needs while minimizing operational complexity. **Key capabilities** - Scalable volumes: 150 L, 1.3 kL, 3 kL, 13 kL and 40kL - Single-site manufacturing to support continuity and speed - Proven operational expertise within Novartis’ microbial competence center --- ### Small Molecules ![Pills icon](/sites/novartis_com/files/styles/crop_freeform/public/2026-06/pills-icon.png.webp?itok=NyrW8oKI "Pills icon") #### Integrated API, drug product, and fill & finish capabilities Novartis provides end-to-end contract manufacturing for oral solid dosage from active pharmaceutical ingredient (API) production through finished drug product and fill & finish. Our sites are equipped to manage complex processes, diverse dosage forms, and global supply requirements. **Key capabilities** - API manufacturing - Oral solid dosage (OSD) forms - Sterile and non-sterile injectables - Integrated fill & finish services - Expertise in Hot Melt Extrusion, nanomilling, wet milling --- ### Cell & Gene (CGT) Viral Vectors ![Virus icon](/sites/novartis_com/files/styles/crop_freeform/public/2026-06/virus-icon.png.webp?itok=Gv3iJNKI "Virus icon") #### Advanced GMP manufacturing for complex modalities Pioneer in advanced therapy manufacturing, offering GMP contract manufacturing for gene-based cell therapies and viral vectors. Our high‑tech facilities are designed to manage the unique challenges of advanced therapies, including complexity, variability, and regulatory rigor. **Key capabilities** - Gene‑modified cell therapy manufacturing (e.g. CAR‑T) - Viral vector manufacturing (e.g. AAV, lentiviral vectors) - Clinical and commercial GMP manufacturing environments - Experience supporting regulated markets --- ### xRNA, LNP, pDNA ![RNA icon](/sites/novartis_com/files/styles/crop_freeform/public/2026-06/rna-icon.png.webp?itok=2DDXMb72 "RNA icon") #### End-to-end GMP support for xRNA therapies Novartis provides comprehensive contract manufacturing support for nucleic acid‑based medicines, enabling partners to advance RNA therapies from early clinical supply to commercial production. **Key capabilities** - Manufacturing of RNA products, including siRNA and mRNA - Master cell bank manufacturing - Plasmid DNA production - Peptide synthesis - Lipid nanoparticle (LNP) formulation - Drug product manufacturing --- ### Fill & Finish ![Syringe icon](/sites/novartis_com/files/styles/crop_freeform/public/2026-06/syringe-icon.png.webp?itok=7wuC3oW9 "Syringe icon") #### Flexible, high-quality GMP drug product solutions Our drug product manufacturing services support a wide range of dosage forms, container systems, and production volumes. We offer both ready‑to‑fill bulk handling and compounding‑based solutions, tailored to program requirements. **Key capabilities** - Aseptic fill & finish - Liquid and lyophilized products - Multiple packaging formats: - Vials - Pre‑filled syringes - Cartridges - Ointments and viscoelastics - Dropper bottles and sprays - Tubes ## Our global manufacturing sites Global network with robust supply chain. Located across Europe, the US and Asia, our cGMP-compliant facilities have the people and technology to create high-end solutions efficiently and at scale. #### Novartis Global Manufacturing Network​​ ![Novartis Global Manufacturing Network​​ Map](/sites/novartis_com/files/styles/crop_freeform/public/2026-07/novartis-global-manufacturing-network-map.jpg.webp?itok=_gPOeiBs "Novartis Global Manufacturing Network​​ Map") [ ![Icon representing a check mark](/sites/novartis_com/files/styles/cards_1_3/public/2026-03/checkmark-icon.jpg.webp?itok=Shj5vytT "Icon representing a check mark") ### Combine quality and regulatory excellence Trusted GMP manufacturing supported by rigorous quality systems and deep regulatory experience across global health authorities. ](/about/quality) [ ![Icon representing a handshake](/sites/novartis_com/files/styles/cards_1_3/public/2026-03/handshake-icon.jpg.webp?itok=fuaJHsMz "Icon representing a handshake") ### Manufacturing Expertise, Scalability & Flexibility Expert-led manufacturing with scalable, flexible operations, enabling reliable tech transfer and clinical‑to‑commercial supply across complex modalities. ](https://www.novartis.com/about/manufacturing/contract-manufacturing#technologies-offering) [ ![Sustainability icon](/sites/novartis_com/files/styles/cards_1_3/public/2026-06/sustainability-icon.png.webp?itok=RcnoTN6K "Sustainability icon") ### Responsible & Sustainable Manufacturing Manufacturing excellence aligned with Novartis’s sustainability commitments, enabling responsible operations and reduced environmental impact across the global network. ](/esg/environmental-sustainability) ## Novartis Contract Manufacturing Factsheets Download our factsheets below to find more information about our services & technologies offering. Previous Next [ ![Globe icon](/sites/novartis_com/files/styles/cards_1_3/public/2026-06/contract-manufacturing-globe-icon.png.webp?itok=H9UCFRec "Globe icon") ### General Capabilities Download our General Capabilities factsheet. ](/about/manufacturing/contract-manufacturing/novartis-cdmo-brochure) [ ![Y Chromosome icon](/sites/novartis_com/files/styles/cards_1_3/public/2026-06/contract-manufacturing-y-chromosome-icon.png.webp?itok=HFq-kg8V "Y Chromosome icon") ### Mammalian Download our Mammalian factsheet. ](/about/manufacturing/contract-manufacturing/novartis-cdmo-brochure) [ ![Pills icon](/sites/novartis_com/files/styles/cards_1_3/public/2026-06/contract-manufacturing-pills-icon.png.webp?itok=2JbRVYPR "Pills icon") ### Small Molecule Download our Small Molecule factsheet. ](/about/manufacturing/contract-manufacturing/novartis-cdmo-brochure) [ ![Laboratory icon](/sites/novartis_com/files/styles/cards_1_3/public/2026-06/contract-manufacturing-laboratory-icon.png.webp?itok=31ns-Yee "Laboratory icon") ### Analytical Services Download our Analytical Services factsheet. ](/about/manufacturing/contract-manufacturing/novartis-cdmo-brochure) [ ![Virus icon](/sites/novartis_com/files/styles/cards_1_3/public/2026-06/contract-manufacturing-virus-icon.png.webp?itok=G_-YYgcO "Virus icon") ### Cell & Gene Download our Cell & Gene factsheet. ](/about/manufacturing/contract-manufacturing/novartis-cdmo-brochure) [ ![Syringe icon](/sites/novartis_com/files/styles/cards_1_3/public/2026-06/contract-manufacturing-syringe-icon.png.webp?itok=k_Z29jFW "Syringe icon") ### Fill Finish Download our Fill Finish factsheet. ](/about/manufacturing/contract-manufacturing/novartis-cdmo-brochure) ## Keep in touch with us ![Icon representing a dialogue](/sites/novartis_com/files/styles/crop_freeform/public/2026-03/feedback-icon.jpg.webp?itok=Vsob9mFw "Icon representing a dialogue") [Follow us on LinkedIn](https://www.linkedin.com/company/novartiscontractmanufacturing/) ![Icon representing a question](/sites/novartis_com/files/styles/crop_freeform/public/2026-03/help-icon.jpg.webp?itok=k_8PVmgz "Icon representing a question") [Contact us](/about/manufacturing/contract-manufacturing/contact "Contract manufacturing contact form")